Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Receptor Biologix
company
About
Receptor Biologix develops receptor-based biological therapeutics for cancer, inflammatory, and autoimmune diseases.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $33.60M
- Industries
- Biotechnology,Health Care,Life Science,Medical,Therapeutics
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Receptor Biologix develops receptor-based biological therapeutics for cancer, inflammatory, and autoimmune diseases. The company is headquartered in Palo Alto, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$33.60M
Receptor Biologix has raised a total of
$33.60M
in funding over 2 rounds. Their latest funding was raised on
Apr 29, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 29, 2005 | Series A | $33.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Receptor Biologix is funded by 1 investors.
Northwest Technology Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Northwest Technology Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
